nach oben

International Journal of Legal Medicine

Erschienen in:

01.03.2012 | Review Article

Postmortem chemistry update part II

verfasst von: Cristian Palmiere, Patrice Mangin

Erschienen in: International Journal of Legal Medicine | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

As a continuation of “Postmortem Chemistry Update Part I,” Part II deals with molecules linked to liver and cardiac functions, alcohol intake and alcohol misuse, myocardial ischemia, inflammation, sepsis, anaphylaxis, and hormonal disturbances. A very important array of new material concerning these situations had appeared in the forensic literature over the last two decades. Some molecules, such as procalcitonin and C-reactive protein, are currently researched in cases of suspected sepsis and inflammation, whereas many other analytes are not integrated into routine casework. As in part I, a literature review concerning a large panel of molecules of forensic interest is presented, as well as the results of our own observations, where possible.

Kumar V (2009) Robbins and Cotran: pathologic basis of disease, 8th edn. Saunders, Philadelphia

Finkbeiner WE, Ursell PC, Davis RL (2004) Autopsy pathology. A manual and atlas. Churchill Livingstone, Philadelphia

Coe JI (1993) Postmortem chemistry update. Emphasis on forensic application. Am J Forensic Med Pathol 14(2):91–117PubMedCrossRef

Särkioja T, Ylä-Herttuala S, Solakivi T, Nikkari T, Hirvonen J (1988) Stability of plasma total cholesterol, triglycerides and apolipoproteins B and A-1 during the early postmortem period. J Forensic Sci 33(6):1432–1438PubMed

Uemura K, Shintani-Ishida K, Saka K, Nakajima M, Ikegaya H, Kikuchi Y, Yoshida K (2008) Biochemical blood markers and sampling sites in forensic autopsy. J Forensic Leg Med 15(5):312–317PubMedCrossRef

Piette M, De Schrijver G (1987) Gamma-glutamyl transferase: applications in forensic pathology. I: study of blood serum recovered from human bodies. Med Sci Law 27(3):152–160PubMed

Sadler DW, Girela E, Pounder DJ (1996) Post mortem markers of chronic alcoholism. Forensic Sci Int 82(2):153–163PubMedCrossRef

Arndt T (2001) Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis and interpretation. Clin Chem 47(1):13–27PubMed

Bortolotti F, De Paoli G, Tagliaro F (2006) Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001–2005. J Chromatogr B Analyt Technol Biomed Life Sci 841(1–2):96–109PubMed

10.

Rainio J, De Giorgio F, Bortolotti F, Tagliaro F (2008) Objective post-mortem diagnosis of chronic alcohol abuse—a review of studies on new markers. Leg Med (Tokyo) 10(5):229–235CrossRef

11.

Delanghe JR, De Buyzere ML (2009) Carbohydrate deficient transferrin and forensic medicine. Clin Chim Acta 406(1–2):1–7PubMedCrossRef

12.

Simonnet C, Dumestre-Toulet V, Kintz P, Gromb S (1999) Review of factors susceptible of influencing postmortem carbohydrate-deficient transferrin. Forensic Sci Int 106(1):7–17PubMedCrossRef

13.

Malcolm R, Anton RF, Conrad SE, Sutherland S (1999) Carbohydrate-deficient transferrin and alcohol use in medical examiner cases. Alcohol 17(1):7–11PubMedCrossRef

14.

Osuna E, Pérez-Cárceles MD, Moreno M, Bedate A, Conejero J, Abenza JM, Martínez P, Luna A (2000) Vitreous humor carbohydrate-deficient transferrin concentrations in the postmortem diagnosis of alcoholism. Forensic Sci Int 108(3):205–213PubMedCrossRef

15.

Berkowicz A, Wallerstedt S, Wall K, Denison H (2001) Carbohydrate-deficient transferrin in vitreous humor: a marker of possible withdrawal-related death in alcoholics. Alcohol Alcohol 36(3):231–234PubMed

16.

Berkowicz A, Wallerstedt S, Wall K, Denison H (2003) Analysis of carbohydrate-deficient transferrin (CDT) in vitreous humor as a forensic tool for detection of alcohol misuse. Forensic Sci Int 137(2–3):119–124PubMedCrossRef

17.

Rainio J, De Paoli G, Druid H, Kauppila R, De Giorgio F, Bortolotti F, Tagliaro F (2008) Postmortem stability and redistribution of carbohydrate-deficient transferrin (CDT). Forensic Sci Int 174(2–3):161–165PubMedCrossRef

18.

Schmitt G, Droenner P, Skopp G, Aderjan R (1997) Ethyl glucuronide concentration in serum of human volunteers, teetotalers, and suspected drinking drivers. J Forensic Sci 42(6):1099–1102PubMed

19.

Wurst FM, Kempter C, Seidl S, Alt A (1999) Ethyl glucuronide: a marker of alcohol consumption and a relapse marker with clinical and forensic implications. Alcohol Alcohol 34(1):71–77PubMed

20.

Wurst FM, Schüttler R, Kempter C, Seidl S, Gilg T, Jachau K, Alt A (1999) Can ethyl glucuronide be determined in post-mortem body fluids and tissues? Alcohol Alcohol 34(2):262–263PubMed

21.

Wurst FM, Kempter C, Metzger J, Seidel S, Alt A (2000) Ethyl glucuronide: a marker of recent alcohol consumption with clinical and forensic implications. Alcohol 20(2):111–116PubMedCrossRef

22.

Alt A, Janda I, Seidl S, Wurst FM (2000) Determination of ethyl glucuronide in hair samples. Alcohol Alcohol 35(3):313–314PubMed

23.

Skopp G, Schmitt G, Pötsch L, Drönner P, Aderjan R, Mattern R (2000) Ethyl glucuronide in human hair. Alcohol Alcohol 35(3):283–285PubMed

24.

Seidel S, Wurst FM, Alt A (2001) Ethyl glucuronide—a biological marker for recent alcohol consumption. Addict Biol 6(3):205–212CrossRef

25.

Yegles M, Labarthe A, Auwärter V, Hartwig S, Vater R, Wennig R, Pragst F (2004) Comparison of ethyl glucuronide and fatty acid ethyl ester concentrations in hair of alcoholics, social drinkers and teetotallers. Forensic Sci Int 145(2–3):167–173PubMedCrossRef

26.

Jurado C, Soriano T, Giménez MP, Menédez M (2004) Diagnosis of chronic alcohol consumption. Hair analysis for ethyl-glucuronide. Forensic Sci Int 145(2–3):161–166PubMedCrossRef

27.

Schloegl H, Dresen S, Spaczynski K, Stoertzel M, Wurst FM, Weinmann W (2006) Stability of ethyl glucuronide in urine, post-mortem tissue and blood samples. Int J Legal Med 120(2):83–88PubMedCrossRef

28.

Schloegl H, Rost T, Schmidt W, Wurst FM, Weinmann W (2006) Distribution of ethyl glucuronide in rib bone marrow, other tissues and body liquids as proof of alcohol consumption before death. Forensic Sci Int 156(2–3):213–218PubMedCrossRef

29.

Politi L, Zucchella A, Morini L, Stranesi C, Polettini A (2006) Markers of chronic alcohol use in hair: comparison of ethyl glucuronide and cocaethylene in cocaine users. Forensic Sci Int 172(1):23–27PubMedCrossRef

30.

Politi L, Morini L, Leone F, Polettini A (2006) Ethyl glucuronide in hair: is it a reliable marker of chronic high levels of alcohol consumption? Addiction 101(10):1408–1412PubMedCrossRef

31.

Høiseth G, Karinen R, Christophersen AS, Olsen L, Normann PT, Mørland J (2007) A study of ethyl glucuronide in post-mortem blood as a marker of ante-mortem ingestion of alcohol. Forensic Sci Int 165(1):41–45PubMedCrossRef

32.

Høiseth G, Karinen R, Johnsen L, Normann PT, Christophersen AS, Mørland J (2008) Disappearance of ethyl glucuronide during heavy putrefaction. Forensic Sci Int 176(2–3):147–151PubMedCrossRef

33.

Kharbouche H, Sporkert F, Staub C, Mangin P, Augsburger M (2009) Ethyl glucuronide: a biomarker of alcohol consumption. Praxis 98(22):1299–1306 (Bern 1994)PubMedCrossRef

34.

Morini L, Politi L, Acito S, Groppi A, Polettini A (2009) Comparison of ethyl glucuronide in hair with carbohydrate-deficient transferrin in serum as markers of chronic high levels of alcohol consumption. Forensic Sci Int 188(1–3):140–143PubMedCrossRef

35.

Morini L, Politi L, Polettini A (2009) Ethyl glucuronide in hair. A sensitive and specific marker of chronic heavy drinking. Addiction 104(6):915–920PubMedCrossRef

36.

Pragst F, Rothe M, Moench B, Hastedt M, Herre S, Simmert D (2010) Combined use of fatty acid ethyl esters and ethyl glucuronide in hair for diagnosis of alcohol abuse: interpretation and advantages. Forensic Sci Int 196(1–3):101–110PubMedCrossRef

37.

Liniger B, Nguyen A, Friedrich-Koch A, Yegles M (2010) Abstinence monitoring of suspected drinking drivers: ethyl glucuronide in hair versus CDT. Traffic Inj Prev 11(2):123–126PubMedCrossRef

38.

Høiseth G, Karinen R, Christophersen AS, Mørland J (2010) Practical use of ethyl glucuronide and ethyl sulfate in postmortem cases as markers of antemortem alcohol ingestion. Int J Legal Med 124(2):143–148PubMedCrossRef

39.

Kronstrand R, Brinkhagen L, Nyström FH (2011) Ethyl glucuronide in human hair after daily consumption of 16 or 32 g of ethanol for 3 months. Forensic Sci Int. doi:10.1016/j.forsciint.2011.01.044

40.

Dahl H, Voltaire Carlsson A, Hillgren K, Helander A (2011) Urinary ethyl glucuronide and ethyl sulfate testing for detection of recent drinking in an outpatient treatment program for alcohol and drug dependence. Alcohol Alcohol 46(3):278–282PubMed

41.

Helander A, Olsson I, Dahl H (2007) Postcollection synthesis of ethyl glucuronide by bacteria in urine may cause false identification of alcohol consumption. Clin Chem 53(10):1855–1857PubMedCrossRef

42.

Wurst FM, Dresen S, Allen JP, Wiesbeck G, Graf M, Weinmann W (2006) Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption. Addiction 101(2):204–211PubMedCrossRef

43.

Baranowski S, Serr A, Thierauf A, Weinmann W, Grosse Perdekamp M, Wurst FM, Halter CC (2008) In vitro study of bacterial degradation of ethyl glucuronide and ethyl sulfate. Int J Legal Med 122(5):389–393PubMedCrossRef

44.

Halter CC, Laengin A, Al-Ahmad A, Wurst FM, Weinmann W, Kuemmerer K (2009) Assessment of the stability of the ethanol metabolite athyl sulfate in standardized degradation tests. Forensic Sci Int 186(1–3):52–55PubMedCrossRef

45.

Thierauf A, Serr A, Halter CC, Al-Ahmad A, Rana S, Weinmann W (2008) Influence of preservatives on the stability of ethyl glucuronide and ethyl sulphate in urine. Forensic Sci Int 182(1–2):41–45PubMedCrossRef

46.

Thierauf A, Kempf J, Grosse Perdekamp M, Auwärter V, Gnann H, Wohlfarth A, Weinmann W (2011) Ethyl sulphate and ethyl glucuronide in vitreous humor as postmortem evidence marker for ethanol consumption prior to death. Forensic Sci Int 210(1–3):63–68PubMedCrossRef

47.

Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambahashi Y, Inouye K, Imura H (1991) Brain natriuretic peptide as a novel cardiac hormone in humans—evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87:1402–1412PubMedCrossRef

48.

Dagnino L, Drouin J, Nemer M (1991) Differential expression of natriuretic peptide genes in cardiac and extracardiac tissues. Mol Endocrinol 5:1292–1300PubMedCrossRef

49.

Takahashi T, Allen PD, Izumo S (1992) Expression of A-, B- and C-type natriuretic peptide genes in failing and developing human ventricles—correlation with expression of the Ca(2+)-ATPase gene. Circ Res 71:9–17PubMed

50.

Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, Nakao K (1993) Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88:82–91PubMed

51.

Hill NS, Klinger JR, Warbuton RR, Pietras L, Wrenn DS (1994) Brain natriuretic peptide: possible role in the modulation of hypoxic pulmonary hypertension. Am J Physiol 266:308–315

52.

Yandle TG (1994) Biochemistry of natriuretic peptides. J Intern Med 235(6):561–576PubMedCrossRef

53.

Ogawa Y, Nakao K (1995) Brain natriuretic peptide as a cardiac hormone in cardiovascular disorders. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis and management, vol 1. Raven, New York, pp 833–840

54.

Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, Masuda I, Nakanishi K, Yoshimasa T, Hashimoto Y, Yamaguchi M, Hori R, Yasue H, Nakao K (1995) Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92(6):1558–1564PubMed

55.

Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H (1996) Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28:22–30PubMed

56.

Tanaka T, Hasegawa K, Fujita M, Tamaki SI, Yamazato A, Kihara Y, Nohara R, Sasayama S (1998) Marked elevation of brain natriuretic peptide levels in pericardial fluid is closely associated with left ventricular dysfunction. J Am Coll Cardiol 31(2):399–403PubMedCrossRef

57.

Ruskoaho H (2003) Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 24(3):341–356PubMedCrossRef

58.

Ala-Kopsala M, Ruskoaho H, Leppäluoto J, Seres L, Skoumal R, Toth M, Horkay F, Vuolteenaho O (2005) Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides. Clin Chem 51(4):708–718PubMedCrossRef

59.

Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Tanaka S, Kamikodai Y, Tsuda K, Okazaki S, Maeda H (2007) Postmortem pericardial natriuretic peptides as markers of cardiac function in medico-legal autopsies. Int J Legal Med 121:28–35PubMedCrossRef

60.

Michaud K, Augsburger M, Donzé N, Sabatasso S, Faouzi M, Bollmann M, Mangin P (2008) Evaluation of postmortem measurement of NT-proBNP as a marker for cardiac function. Int J Legal Med 122:415–420PubMedCrossRef

61.

Osuna E, Pérez-Cárceles MD, Alvarez MV, Noguera J, Luna A (1998) Cardiac troponin I (cTn I) and the postmortem diagnosis of myocardial infarction. Int J Legal Med 111:173–176PubMedCrossRef

62.

Ellingsen CL, Hetland Ø (2003) Serum concentrations of cardiac troponin T in sudden death. Am J Forensic Med Pathol 25(3):213–215

63.

Davies SJ, Gaze DC, Collinson PO (2005) Investigation of cardiac troponins in postmortem subjects: comparing antemortem and postmortem levels. Am J Forensic Med Pathol 26(3):213–215PubMedCrossRef

64.

Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Oritani S, Kamikodai Y, Tsuda K, Okazaki S, Maeda H (2006) Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 1. Analysis with special regard to traumatic causes of death. Leg Med (Tokyo) 8(2):86–93CrossRef

65.

Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Kamikodai Y, Tsuda K, Okazaki S, Maeda H (2006) Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 2: analysis for application in the diagnosis of sudden cardiac death with regard to pathology. Leg Med (Tokyo) 8(2):94–101CrossRef

66.

Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Bessho Y, Kamikodai Y, Tsuda K, Okazaki S, Maeda H (2007) Postmortem cardiac troponin I and creatine kinase MB levels in the blood and pericardial fluid as markers of myocardial damage in medicolegal autopsy. Leg Med (Tokyo) 9(5):241–250CrossRef

67.

Batalis NI, Marcus BJ, Papadea CN, Collins KA (2010) The role of postmortem cardiac markers in the diagnosis of acute myocardial infarction. J Forensic Sci 55(4):1088–1091PubMedCrossRef

68.

Whang KT, Steinwald PM, White JC, Nylen ES, Snider RH, Simon GL, Goldberg RL, Becker KL (1998) Serum calcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab 83(9):3296–3301PubMedCrossRef

69.

Maruna P, Nedelníková K, Gürlich R (2000) Physiology and genetics of procalcitonin. Physiol Res 49(Suppl 1):S57–S61PubMed

70.

Meisner M (2002) Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 323(1–2):17–29PubMedCrossRef

71.

Becker KL, Nylén ES, White JC, Müller B, Snider RH (2004) Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89(4):1512–1525PubMedCrossRef

72.

Becker KL, Snider R, Nyles ES (2008) Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitation. Crit Care Med 36(3):941–952PubMedCrossRef

73.

Becker KL, Snider R, Nyles ES (2010) Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol 159(2):253–264PubMedCrossRef

74.

Sudhir U, Venkatachalaian RK, Kumar TA, Rao MY, Kempegowda P (2011) Significance of serum procalcitonin in sepsis. Indian J Crit Care Med 15(1):1–5PubMedCrossRef

75.

Tsokos M, Reichelt U, Nierhaus A, Püschel K (2001) Serum procalcitonin (PCT): a valuable biochemical parameter for the postmortem diagnosis of sepsis. Int J Legal Med 114(4–5):237–243PubMedCrossRef

76.

Ramsthaler F, Kettner M, Mall G, Bratzke H (2008) The use of rapid diagnostic test of procalcitonine serum levels for the postmortem diagnosis of sepsis. Forensic Sci Int 178(2–3):139–145PubMedCrossRef

77.

Tsokos M, Reichelt U, Jung R, Nierhaus A, Püschel K (2001) Interleukin-6 and C-reactive protein serum levels in sepsis-related fatalities during the early postmortem period. Forensic Sci Int 119(1):47–56PubMedCrossRef

78.

Uhlin-Hansen L (2001) C-reactive protein (CRP), a comparison of pre- and postmortem blood levels. Forensic Sci Int 124(1):32–35PubMedCrossRef

79.

Fujita MQ, Zhu BL, Ishida K, Quan L, Oritani S, Maeda H (2002) Serum C-reactive protein levels in postmortem blood—an analysis with special reference to the cause of death and survival time. Forensic Sci Int 130(2–3):160–166PubMedCrossRef

80.

Astrup BS, Thomsen JL (2007) The routine use of C-reactive protein in forensic investigations. Forensic Sci Int 172(1):49–55PubMedCrossRef

81.

Maeda H, Zhu BL, Bessho Y, Ishikawa T, Quan L, Michiue T, Zhao D, Li DR, Komatsu A (2008) Postmortem serum nitrogen compounds and C-reactive protein levels with special regard to investigation of fatal hyperthermia. Forensic Sci Med Pathol 4(3):175–180PubMedCrossRef

82.

Ishikawa T, Hamel M, Zhu BL, Li DR, Zhao D, Michiue T, Maeda H (2008) Comparative evaluation of postmortem serum concentrations of neopterin and C-reactive protein. Forensic Sci Int 179(2–3):135–143PubMedCrossRef

83.

Reichelt U, Jung R, Nierhaus A, Tsokos M (2005) Serial monitoring of interleukin-1β, soluble interleukin-2 receptor and lipopolysaccharide binding protein levels after death. A comparative evaluation of potential postmortem markers of sepsis. Int J Legal Med 119(2):80–87PubMedCrossRef

84.

Schumann RR, Kirschning CJ, Unbehaun A, Aberle HP, Knope HP, Lamping N, Ulevitch RJ, Herrmann F (1996) The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol 16(7):3490–3503PubMed

85.

Sakr Y, Burgett U, Nacul F, Reinhart K, Brunkhorst F (2008) Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis? Crit Care Med 36(7):2014–2022PubMedCrossRef

86.

Schrag B, Roux-Lombard P, Schneiter D, Vaucher P, Mangin P, Palmiere C (2011) Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6 and interleukin-8 as diagnostic parameters in sepsis-related fatalities. Int J Legal Med. doi:10.1007/s00414-011-0596-z

87.

Mimasaka S, Hashiyada M, Nata M, Funayama M (2001) Correlation between serum IL-6 levels and death: usefulness in diagnosis of “Traumatic shock”? Tohoku J Exp Med 193(4):319–324PubMedCrossRef

88.

Mimasaka S (2002) Postmortem cytokine levels and the cause of death. Tohoku J Exp Med 197(3):145–150PubMedCrossRef

89.

Mimasaka S, Ohtsu Y, Tsunenari S, Funayama M (2006) Postmortem cytokine levels and severity of traumatic injuries. Int J Legal Med 120(5):265–270PubMedCrossRef

90.

Mimasaka S, Funayama M, Hashiyada M, Nata M, Tsunenari S (2007) Significance of levels of IL-6 and IL-8 after trauma: a study of 11 cytokines post-mortem using multiplex immunoassay. Injury 38(9):1047–1051PubMedCrossRef

91.

Hoffmann G, Wirleitner B, Fuchs D (2003) Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res 52(8):313–321PubMedCrossRef

92.

Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, Price RW, Fuchs D (2010) Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther 3:7–15

93.

Ambach E, Tributsch W, Fuchs D, Reibnegger G, Henn R, Wachter H (1991) Postmortem evaluation of serum and urine neopterin concentrations. J Forensic Sci 36(4):1089–1093PubMed

94.

Ambach E, Tributsch W, Rabl W, Fuchs D, Reibnegger G, Henn R, Wachter H (1991) Postmortem neopterin concentrations: comparison of diagnoses with and without cellular immunological background. Int J Legal Med 104(5):259–262PubMedCrossRef

95.

Payne V, Kam CA (2004) Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 59:695–703PubMedCrossRef

96.

Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology (2005) The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 115:S483–S523CrossRef

97.

Hogan AD, Schwartz LB (1997) Markers of mast cell degranulation. Methods 13(1):43–52PubMedCrossRef

98.

Caughey GH (2006) Tryptase genetics and anaphylaxis. J Allergy Clin Immunol 117(6):1411–1414PubMedCrossRef

99.

Edston E, van Hage-Hamsten M (1996) Tryptase—at last a useful diagnostic marker for anaphylactic death. Allergy 51(6):443–445PubMed

100.

Edston E, van Hage-Hamsten M (1998) β-Tryptase measurements postmortem in anaphylactic deaths and in control. Forensic Sci Int 93(2–3):135–142PubMedCrossRef

101.

Yunginger JW, Nelson DR, Squillace DL, Jones RT, Holley KE, Hyma BA, Schwartz LB (1991) Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci 36(3):857–865PubMed

102.

Ansari MQ, Zamora JL, Lipscomb MF (1993) Postmortem diagnosis of acute anaphylaxis by serum tryptase analysis. A case report. Am J Clin Pathol 99(1):101–103PubMed

103.

Fineschi V, Monasterolo G, Rosi R, Turillazzi E (1999) Fatal anaphylactic shock during a fluorescein angiography. Forensic Sci Int 100(1–2):137–142PubMedCrossRef

104.

Pumphrey RS, Roberts IS (2000) Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 53(4):273–276PubMedCrossRef

105.

Konarzewski W, De’Ath S (2001) Unrecognised fatal anaphylactic reaction to propofol or fentanyl. Anaesthesia 56:497–498PubMedCrossRef

106.

Way MG, Baxendine CL (2002) The significance of postmortem tryptase levels in supporting a diagnosis of anaphylaxis. Anaesthesia 57:310–311PubMedCrossRef

107.

Riches KJ, Gillis D, James RA (2002) A autopsy approach to bee sting-related deaths. Pathology 34(3):257–262PubMedCrossRef

108.

Edston E, van Hage-Hamsten M (2003) Death in anaphylaxis in a man with house dust mite allergy. Int J Legal Med 117(5):299–301PubMedCrossRef

109.

Hitosugi M, Omura K, Yokoyama T, Kawato H, Motozawa Y, Nagai T, Tokudome S (2004) An autopsy case of fatal anaphylactic shock following fluorescein angiography: a case report. Med Sci Law 44(3):264–265PubMedCrossRef

110.

Low I, Stables S (2006) Anaphylactic deaths in Auckland, New Zeland: a review of coronial autopsies from 1985 to 2005. Pathology 38(4):328–332PubMedCrossRef

111.

Edston E, Eriksson O, van Hage-Hamsten M (2007) Mast cell tryptase in postmortem serum—reference values and confounders. Int J Legal Med 121(4):275–280PubMedCrossRef

112.

Osawa M, Satoh F, Horiuchi H, Tian W, Kugota N, Hasegawa I (2008) Postmortem diagnosis of fatal anaphylaxis during intravenous administration of therapeutic and diagnostic agents: evaluation of clinical laboratory parameters and immunohistochemistry in three cases. Leg Med (Tokyo) 179(2–3):135–143

113.

Platt MS, Yunginger JW, Sekula-Perlman A, Irani AM, Smialek J, Mirchandani HG, Schwartz LB (1994) Involvement of mast cells in sudden infant death syndrome. J Allergy Clin Immunol 94:250–256PubMed

114.

Holgate S, Walters C, Walls AF, Lawrence S, Shell DJ, Variend S, Fleming PJ, Berry PJ, Gilbert RE, Robinson C (1994) The anaphylaxis hypothesis of sudden infant death syndrome (SIDS): mast cell degranulation in cot death revealed by elevated concentrations of tryptase in serum. Clin Exp Allergy 24:1115–1122PubMed

115.

Randall B, Butts J, Halsey F (1995) Elevated postmortem tryptase in the absence of anaphylaxis. J Forensic Sci 40:208–211PubMed

116.

Edston E, van Hage-Hamsten M (1997) Anaphylactoid shock—a common cause of death in heroin addicts? Allergy 52(9):950–954PubMedCrossRef

117.

Edston E, Gidlund E, Wickman M, Ribbing H, van Hage-Hamsten M (1999) Increased mast cell tryptase in sudden infant death—anaphylaxis, hypoxia or artifact? Clin Exp Allergy 29(12):1648–1654PubMedCrossRef

118.

Fineschi V, Cecchi R, Centini F, Paglicci Reattelli L, Turillazzi E (2001) Immunohistochemical quantification of pulmonary mast-cells and post-mortem blood dosages of tryptases and eosinophil cationic protein in 48 heroin-related deaths. Forensic Sci Int 120(3):189–194PubMedCrossRef

119.

Buckley MG, Variend S, Walls AF (2001) Elevated serum concentrations of beta-tryptase, but not alpha-tryptase, in sudden death infant syndrome. An investigation of anaphylactic mechanisms. Clin Exp Allergy 31(11):1696–1704PubMedCrossRef

120.

Edston E, van Hage-Hamsten M (2003) Mast cell tryptase and hemolysis after trauma. Forensic Sci Int 131(1):8–13PubMedCrossRef

121.

Nishio H, Suzuki K (2004) Serum tryptase levels in sudden infant death syndrome in forensic autopsy cases. Forensic Sci Int 139(1):57–60PubMedCrossRef

122.

Horn KD, Halsey JF, Zumwalt RE (2004) Utilisation of serum tryptase and immunoglobulin E assay in the postmortem diagnosis of anaphylaxis. Am J Forensic Med Pathol 25(1):37–43PubMedCrossRef

123.

Da Broi U, Moreschi C (2011) Post-mortem diagnosis of anaphylaxis: a difficult task in forensic medicine. Forensic Sci Int 204(1–3):1–5PubMedCrossRef

124.

Mayer DE, Krauskopf A, Hemmer W, Moritz K, Jarisch R, Reitner C (2011) Usefulness of post mortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxis. Forensic Sci Int. doi:10.1016/j.forsciint.2011.05.020

125.

Nishio H, Takai S, Miyazaki M, Horiuchi H, Osawa M, Uemura K, Yoshida K, Mukaida M, Ueno Y, Suzuki K (2005) Usefulness of serum mast cell-specific chymase levels for postmortem diagnosis of anaphylaxis. Int J Legal Med 119(6):331–334PubMedCrossRef

126.

Ishikawa T, Quan L, Li DR, Zhao D, Michiue T, Hamel M, Maeda H (2008) Postmortem biochemistry and immunohistochemistry of adrenocorticotropic hormone with special regard to fatal hypothermia. Forensic Sci Int 179(2–3):147–151PubMedCrossRef

127.

Ishikawa T, Miyaishi S, Tachibana T, Ishizu H, Zhu BL, Maeda H (2004) Fatal hypothermia related vacuolation of hormone-producing cells in the anterior pituitary. Leg Med (Tokyo) 6(3):157–163CrossRef

128.

Müller E, Franke WG, Koch R (1997) Thyreoglobulin and violent asphyxia. Forensic Sci Int 90(3):165–170PubMedCrossRef

129.

Şenol E, Demirel B, Akar T, Gülbahar O, Bakar C, Bukan N (2008) The analysis of hormones and enzymes extracted from endocrine glands of the neck region in deaths due to hanging. Am J Forensic Med Pathol 29(1):49–54PubMedCrossRef

130.

Edston E, Druid H, Holmgren P, Oström M (2001) Postmortem measurements of thyroid hormones in blood and vitreous humor combined with histology. Am J Forensic Med Pathol 22(1):78–83PubMedCrossRef

131.

Dressler J, Mueller E (2006) High thyroglobulin (Tg) concentrations in fatal traumatic brain injuries. Am J Forensic Med Pathol 27(3):280–282PubMedCrossRef

132.

Ishikawa T, Michiue T, Zhao D, Komatsu A, Azuma Y, Quan L, Hamel M, Maeda H (2009) Evaluation of postmortem serum and cerebrospinal fluid levels of thyroid-stimulating hormone with special regard to fatal hypothermia. Leg Med Tokyo 11(1):S228–S230PubMedCrossRef

133.

Zhu BL, Ishikawa T, Michiue T, Li DR, Zhao D, Quan L, Oritani S, Bessho Y, Maeda H (2007) Postmortem serum catecholamine levels in relation to the cause of death. Forensic Sci Int 173(2–3):122–129PubMedCrossRef

134.

Wilke N, Janssen H, Fahrenhorst C, Hecker H, Manns MP, Brabant EG, Tröger HD, Breitmeier D (2007) Postmortem determination of concentrations of stress hormones in various body fluids—is there a dependency between adrenaline/noradrenaline quotient, cause of death and agony time? Int J Legal Med 121(5):385–394PubMedCrossRef

135.

Ishikawa T, Yoshida C, Michiue T, Perdekamp MG, Pollak S, Maeda H (2010) Immunohistochemistry of catecholamine in the hypothalamic-pituitary-adrenal system with special regard to fatal hypothermia and hyperthermia. Leg Med (Tokyo) 12(3):121–127CrossRef

136.

Finlayson NB (1965) Blood cortisol in infants and adults: a postmortem study. J Pediatr 67:284–292CrossRef

137.

Kubo S, Kitamura O, Orihara Y, Tsuda R, Hirose W, Nakasono I (1997) Isolated adrenocorticotropic hormone deficiency: an autopsy case of adrenal crisis. A case report. Am J Forensic Med Pathol 18(2):202–205PubMedCrossRef

138.

Al Sabri AM, Smith N, Busuttil A (1997) Sudden death due to auto-immune Addison’s disease in a 12-year-old girl. Int J Legal Med 110(5):278–280PubMedCrossRef

139.

Burke MP, Opeskin K (1999) Adrenocortical insufficiency. Am J Forensic Med Pathol 20(1):60–65PubMedCrossRef

140.

Clapper A, Nashelsky M, Dailey M (2008) Evaluation of serum cortisol in the postmortem diagnosis of acute adrenal insufficiency. Am J Forensic Med Pathol 29(2):181–184PubMedCrossRef

141.

Fanton L, Bévalot F, Cartiser N, Palmiere C, Le Meur C, Malicier D (2010) Postmortem measurement of human chorionic gonadotropin in vitreous humor and bile. J Forensic Sci 55(3):792–794PubMedCrossRef

142.

Marsden JT (2006) Erythropoietin—measurement and clinical applications. Ann Clin Biochem 43:97–104PubMedCrossRef

143.

Quan L, Zhu BL, Ishikawa T, Michiue T, Zhao D, Li DR, Ogawa M, Maeda H (2008) Postmortem serum erythropoietin levels in establishing the cause of death and survival time at medicolegal autopsy. Int J Legal Med 122(6):481–487PubMedCrossRef

144.

Quan L, Zhu BL, Ishikawa T, Michiue T, Zhao D, Ogawa M, Maeda H (2010) Postmortem serum erythropoietin level as a marker of survival time in injury deaths. Forensic Sci Int 200(1–3):117–122PubMedCrossRef

145.

Yoshida C, Ishikawa T, Michiue T, Quan L, Maeda H (2011) Postmortem biochemistry and immunohistochemistry of chromogranin A as a stress marker with special regard to fatal hypothermia and hyperthermia. Int J Legal Med 125(1):11–20PubMedCrossRef

146.

Li DR, Zhu BL, Ishikawa T, Zhao D, Michiue T, Maeda H (2006) Postmortem serum protein S100B levels with regard to the cause of death involving brain damage in medicolegal autopsy cases. Leg Med (Tokyo) 8(2):71–77CrossRef

147.

Li DR, Zhu BL, Ishikawa T, Zhao D, Michiue T, Maeda H (2006) Immunohistochemical distribution of S-100 protein in the cerebral cortex with regard to the cause of death in forensic autopsy. Leg Med (Tokyo) 8(2):78–85CrossRef

148.

Li DR, Michiue T, Zhu BL, Ishikawa T, Quan L, Zhao D, Yoshida C, Chen JH, Wang Q, Komatsu A, Azuma Y, Maeda H (2009) Evaluation of postmortem S100B levels in the cerebrospinal fluid with regard to the cause of death in medicolegal autopsy. Leg Med Tokyo 11(1):S273–S275PubMedCrossRef

149.

Li DR, Ishikawa T, Quan L, Zhao D, Michiue T, Zhu BL, Wang HJ, Maeda H (2010) Morphological analysis of astrocytes in the hippocampus in mechanical asphyxiation. Leg Med (Tokyo) 12(2):63–67CrossRef

150.

Quan L, Ishikawa T, Hara J, Michiue T, Chen JH, Wang Q, Zhu BL, Maeda H (2011) Postmortem serotonin levels in cerebrospinal and pericardial fluids with regard to the cause of death in medicolegal autopsy. Leg Med (Tokyo) 13(2):75–78CrossRef

151.

Musshoff F, Menting T, Madea B (2004) Postmortem serotonin (5-HT) concentrations in the cerebrospinal fluid of medicolegal cases. Forensic Sci Int 142(2–3):211–219PubMedCrossRef

152.

Püschel K, Lockemann U, Bartel J (1995) Postmortem investigation of serum myoglobin levels with special reference to electrical fatalities. Forensic Sci Int 72(3):171–177PubMedCrossRef

153.

Fieguth A, Schumann G, Tröger HD, Kleemann WJ (1999) The effect of lethal electrical shock on postmortem serum myoglobin concentrations. Forensic Sci Int 105(2):75–82PubMedCrossRef

154.

Zhu BL, Ishida K, Quan L, Taniguchi M, Oritani S, Kamikodai Y, Fujita MQ, Maeda H (2001) Post-mortem urinary myoglobin levels with reference to the cause of death. Forensic Sci Int 115(3):183–188PubMedCrossRef

Titel: Postmortem chemistry update part II
verfasst von: Cristian Palmiere
Patrice Mangin
Publikationsdatum: 01.03.2012
Verlag: Springer-Verlag
Erschienen in: International Journal of Legal Medicine / Ausgabe 2/2012
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI: https://doi.org/10.1007/s00414-011-0614-1

Springer Medizin

Postmortem chemistry update part II

Abstract

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2012

Ballistic parameters and trauma potential of direct-acting, powder-actuated fastening tools (nail guns)

Studies on the phase I metabolism of the new designer drug 3-fluoromethcathinone using rabbit liver slices

Diagnostic performance of ethyl glucuronide in hair for the investigation of alcohol drinking behavior: a comparison with traditional biomarkers

Forensic DNA research: keeping it real

Demonstration of liver metastases on postmortem whole body CT angiography following inadvertent systemic venous infusion of the contrast medium

Reclassification of SIDS cases—a need for adjustment of the San Diego classification?

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie